Detailed Information
Cited 0 time in 
Cited 0 time in 
Cited 0 time in
Metadata Downloads
Phase Ib study of venadaparib, a potent and selective PARP inhibitor, in homologous recombination repair (HRR) mutated breast cancer
- Authors
- Im, S-A.; Kim, J. E.; Lee, K. S.; Moon, Y. W.; Ahn, H. K.; Ock, C-Y.; Roh, E-J.; Lee, M.; Hong, M. J.; Song, S.; Lee, K-H.; Lee, W. S.
- Issue Date
- Sep-2021
- Publisher
- ELSEVIER
- Citation
- ANNALS OF ONCOLOGY, v.32, pp.S480 - S480
- Journal Title
- ANNALS OF ONCOLOGY
- Volume
- 32
- Start Page
- S480
- End Page
- S480
- ISSN
- 0923-7534
- Files in This Item
- There are no files associated with this item.
- Appears in
Collections - 의과대학 > 의학과 > 1. Journal Articles
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
Related Researcher
- Ahn, Hee Kyung
- College of Medicine (Department of Medicine)